chrisvoncsefalvay/vaers-outcomes huggingface dataset:
irritable, crying inconsolably for 12hr;po intake yesterday dec;to ER w/temp 100-102;transferred to CHMC ctr for further eval;19JUN95 f/u prev well 6 to 7 hr of inconsolable fussiness, unresponsive to APAP & parental soothing;
Immediately after injection, had headache, nausea, vomiting and metallic taste in mouth.  Given 50mg Benadryl with improvement.  Nausea/vomiting, metallic taste resolved after 24 hours.  Headache and muscle aches lasted 48 hours and improving.
From Monday (3/22/21) to Friday, I could hardly breathe. My resting heart rate was around 110-120bpm. On Wednesday I went to the Hospital and for chest pain (when I would breathe in), shortness of breath, rapid heart rate, and a fever (on Monday). They rain many tests with chest scans and found all to be clear except I had a ?extremely elevated? white blood cell count. They said they ran blood tests and did not think I had blood clots and they did an MRI and chest x-ray and could not find anything. They sent me home to rest. The rest of the week I had trouble breathing and it slowly started getting better on Friday.
pt recv vax & devel nerve damage;no other info is available as of the date of this report;the reporter wishes to remain anonymous
I got the vaccine at 3:20pm on Sunday 8/15/21. Woke up with body aches at 1 am Monday 8/16/21. Went downstairs for water and medicine at 2 am. Felt off, went back upstairs, laid in bed,  woke up my husband in time to tell him I was going to pass out and then immediately fainted while laying on my bed. I came too, ate bread, took ibuprofen, and went back to sleep. 8/16/21 I experienced normal fatigue, injection site soreness, lymph nodes swollen under injection site arm, body aches. I took ibuprofen every 4-6 hours. Tuesday 8/17/21 around 9 am I started experiencing shortness of breath and mild chest pain. At 10 am I noticed redness and swelling at injection site.  I contacted my primary care physician who wanted me to go the the ER. I called my Allergist who was able to see me at 2pm. At 11am I took my albuterol inhaler which improved the symptoms. The appointment with the allergist proved that the albuterol did improve my air way function after a spirometry test. Dr concluded it was asthma exacerbation as a reaction to the COVID-19 vaccine received on 8/15/21. She prescribed albuterol inhaler 3-4x a day.
Pt presented 2 hour after injection with fever, chills, palpitation and shortness of breath and extreme Fear with crying
"Soreness of abdominal muscles" Pt on pins and needles on upper and lower extremities and lower back. Tx TYLENOL 2 tdbs q 4hrs. PRN pain/soreness
On January 5, 2022, I woke up feeling dizzy, light headed, disoriented and had trouble breathing.  My blood pressure was 90 systolic and my oxygen level/O2 saturation was at 85%, both taken at home.  Since both were low, I was taken to the local ER.  I was admitted to the hospital.  Principal diagnosis was right pulmonary embolus, associated diagnosis was hypoxia, elevated troponin, and diabetes melititus.  I was discharged on January 8, 2022 after being given Eliquis to dissolve the blood clots and will remain on this medication until further notice from PCP.
headache; stomach was bothering; had to run to the bathroom several times; feeling horrible; body aches; nausea; Dizzy; This is a spontaneous report from a contactable consumer (patient). A 62-years-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on 15Feb2021 (Batch/Lot Number: EN9581) as 2nd dose, single for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient previously took the first dose of   BNT162b2 on an unspecified date and he had no effects. The patient reported that he woke up on 16Feb2021 feeling horrible, with body aches and nausea. On 17Feb2021 he felt a little better, but on 18Feb2021 he woke up with a headache and had to run to the bathroom several times, his stomach was bothering him on 18Feb2021. On an unspecified date in Feb2021. The patient stated that he felt like his whole body was aching and he had bad headache. He was feeling better than the day before reporting because he was still not feeling like an 100%. He got a bad headache, he felt little bit dizzy and he ran to the bathroom several times which was he did not know his stomach was bothering. The event pain, feeling horrible and nausea were resolving, the outcome of the other events was unknown.   No follow-up attempts are possible. No further information is expected.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 75-year-old male patient received BNT162b2 (BNT162B2), on 15Jun2022 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 74 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "SLL/CLL - never treated, no symptoms" (unspecified if ongoing), notes: SLL/CLL - never treated, no symptoms; "SLL/CLL - never treated, no symptoms" (unspecified if ongoing), notes: SLL/CLL - never treated, no symptoms. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: The patient has no known allergies.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201337240 same patient, different vaccine dose number, different event;
Headache, chills, fatigue, numbness and tingling on both arms and hands,  and left leg.  I took Tylenol to treat  my symptoms, but I'm still in pain.
Several hours after receiving BEXSERO injection, patient noticed facial swelling, nausea, dizziness, and difficulty swallowing. Later she developed itchy, painful hives on hands, shoulders, and chest. She sought treatment about 24 hours after the injection due to continued difficulty swallowing and hives. She had taken 400mg of ibuprofen for symptom relief at home and was given cetirizine 10mg po in the clinic. Evaluated by MD: vital signs were stable, exam was normal, and lungs were clear. Discharged home with instructions to continue taking cetirizine. Follow up call 2 days later confirmed resolution of symptoms.
Client received the 1st COVID vaccine (Moderna, Lot # 026C21A, EXP: 07/11/2021) at 14:20. EMT  reported to PHN assistance with patient. Spouse of patient requested an emesis bag from PHN and stated that his spouse felt nausea. PHN approached patient at 14:27, patient is alert and oriented x 4, patient stated, ?I do not feel nauseated, it was only for a small second?. Patient asked if nausea was a normal symptom. Per fact sheet for recipients of Moderna vaccine, nausea is a common sign. Patient refused to be assessed by PHN or EMT. Patient was given water and encouraged to stay 30 minutes for observation, but patient refused the extended observation time. PHN advised client to follow up with primary care provider and gave ER precautions. Patient denies any further nausea and continues to refuse assessment. At 14:41 client left facility with a steady gait.
Near syncope, cool/clammy skin, vomiting, dizziness.  Pt placed on oxygen.  O2 sats were 99% on RA.  Pt allowed to rest for approximately 30 minutes.
Vaccine administered around 8:30AM 11/1/10 pt came to clinic around 11:30AM states she felt dizzy and fainted in the hallway.
After a month the vaccination I had appendicitis and got treated for that. Had smell alternation and I just can't smell the same. Most of the things smells the same.
Information has been received from a registered nurse concerning a male who on 14-MAR-2008 was vaccinated with a 0.65 ml dose of zoster vaccine live (Oka/Merck) and was monitored for 30 minute post vaccination. On 17-MAR-2008 the patient developed 5 inch swelling at the injection site. The patient called the clinic and had follow-up with his primary care physician for medical attention. The outcome was unknown. There was no product quality complaint. Additional information has been requested.
Blood pressures of 200 and 207; RASH; temperatures of about 102 and 102.3; This spontaneous case was reported by a patient and describes the occurrence of HYPERTENSION (Blood pressures of 200 and 207), RASH (RASH) and BODY TEMPERATURE INCREASED (temperatures of about 102 and 102.3) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPERTENSION (Blood pressures of 200 and 207), RASH (RASH) and BODY TEMPERATURE INCREASED (temperatures of about 102 and 102.3). At the time of the report, HYPERTENSION (Blood pressures of 200 and 207), RASH (RASH) and BODY TEMPERATURE INCREASED (temperatures of about 102 and 102.3) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: Blood pressures of 200 and 207. On an unknown date, Body temperature: temperatures of about 102 and 102.3.         Relevant concomitant medications were not reported.  On an unknown date, patient had 2 shots of the Moderna COVID-19 vaccine and experienced rash, Blood pressures of 200 and 207 and temperatures of about 102 and 102.3.  Treatment information was not provided.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Induration of 1 cm diameter at site of injection (induration still present 3 wks later).
severe chills; fever; body aches; fatigue; headache; This is a spontaneous report from a contactable consumer reporting for herself. A 59-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number El9266/expiration date: not provided), via an unspecified route of administration, on 11Feb2021 at 09:00 as a single dose in the left arm for COVID-19 IMMUNIZATION. Relevant medical history included aortic aneurysm on an unspecified date. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number El8982/expiration date: not provided), via an unspecified route of administration, on 22Jan2021 as a single dose for COVID-19 IMMUNIZATION. The patient did not have any known allergies. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included Vitamin D, atorvastatin, metoprolol, and omeprazole. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 11Feb2021 at 09:40 (40 minutes after receiving the vaccine, the patient experienced headache but reported that it was manageable and gone after a few hours. Later that evening on 11Feb2021 at 19:00, the patient experienced severe chills, fever, body aches, headache, fatigue. Symptoms lasted for over 48 hours. The patient started to feel some relief Saturday evening but still had annoyance headache on one side. The patient did not receive any treatment for these events. The outcome of the events severe chills, fever, body aches, headache, fatigue was recovering. Since the vaccination, the patient had not been tested for COVID-19.
fall on May 19 and  admitted to ER May 22  with  subacute R MCA stroke resulting in obtundation and left sided hemiparalysis. Complicating his presentation is acute COVID 19 infection with pneumonia along with acute on chronic systolic  congestive heart failure.
I did experience the fever, head pressure, fatigue, the next day. Those symptoms were gone by the following day. HOWEVER, ringing in both ears then started two days after the vaccination and my ears have been continuously ringing ever since. I have had CONSTANT ringing that can be quite loud at times.
she experienced dizziness and weakness; she experienced dizziness and weakness; This is a spontaneous report from a contactable consumer (patient) via the medical information team. A 70-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot: EL9262, expiry: May2021), via an unspecified route of administration (at the age of 70years) on 27Jan2021 at single dose for covid-19 immunisation. Medical history included hypertension and Crohn's. Concomitant medications included lisinopril, estradiol, levothyroxine and adalimumab (HUMIRA) for Crohn's. The patient received the first dose of the Pfizer-BioNtech Covid-19 vaccine on Wednesday. Next morning (on 28Jan2021) from Thursday until Saturday, she experienced dizziness and weakness as stated, "when I woke I was severely dizzy and just weak and that is continued yesterday, well let's say Thursday, Friday and yesterday. I am feeling better today but I wanted to report that". The patient wanted to know if she should receive the second dose of the vaccine because these two symptoms were reported as signs of a severe allergic reaction and that's a contraindication to receive the second dose of the vaccine. The patient had some blood work done on an unspecified date. The patient took some diphenhydramine hydrochloride (BENADRYL) according to her physician. The patient further stated, "I am just, I guess concerned, it does say on the paperwork that I received that you should not take the second dose if you had a severe allergic reaction which it list the dizziness and weakness one of those included so I am assuming that I should not take the second dose." The patient considered the events as non-serious. The outcome of the events was recovering.
On the evening that the recipient received the vaccine, heart rate increased for two hours, at one point climbing to 140 beats per minute. Her Apple Watch detected atrial fibrillation.  The atrial fibrillation resolved after two hours.
Chills; Had a sore throat; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Had a sore throat) and CHILLS (Chills) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No prior medical history was reported).    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced OROPHARYNGEAL PAIN (Had a sore throat). On 24-Mar-2021, the patient experienced CHILLS (Chills). At the time of the report, OROPHARYNGEAL PAIN (Had a sore throat) and CHILLS (Chills) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  Treatment details included gargling with benzydamine and salt water for sore throat and had taken acetaminophen. Patient stated that she did not have any side effects or problems with the vaccine.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: follow up updated on 21-JUN-2021 :Event out come updated for the event chills and soar throat from unknown to resolved
SUSPECTED COVID-19 INFECTION; REVACCINATION WITH DIFFERENT COVID-19 VACCINE; This spontaneous report received from a consumer via a company representative via media and concerned a 75 year old male. The patient's weight, height, and medical history were not reported. The patient previously received two doses (first and second dose) of covid-19 vaccine (unspecified manufacturer) (dose number in series 1) (suspension for injection, route of admin was not reported batch number: Unknown, expiry: Unknown) dose was not reported, administered on an unspecified date for covid-19 prophylaxis.  It was unknown whether patient had any adverse events following vaccination with two doses of covid-19 vaccine (dose number in series 1). The patient received covid-19 vaccine ad26.cov2.s  (dose number in series 2) (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported, 1 total administered for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. Age at time of vaccination 8 decade old. The product was associated with revaccination with different covid-19 vaccine (dose number in series 2). No concomitant medications were reported.  On an unspecified date, the patient experienced a bad cold and had covid (suspected covid-19 infection) (dose number in series 2).  The consumer stated "My husband and I got 2 jabs plus one booster. all against my better judgment. I just do not like taking new meds or vaccines but I was 73 and my husband was 75. my husband still got covid a bad cold I slept in the same bed every night and did not get it I sprayed lysol like crazy. obviously the vax does not prevent you from catching covid or spreading it. so no reason to continue to get these boosters that do not work and last just weeks and if you do the research. we were the lab rats read further and you will find out all the other things they cause including death!" The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the suspected covid-19 infection and revaccination with different covid-19 vaccine was not reported. This report was non-serious.
Red size of golf ball (diameter), puffy, 3 inches above elbow-about 6 hours after shot no treatment needed.
Dizziness, Headache, Myalgia, NauseaVomiting, Cough and stuffy nose Narrative:
Patient got COVID-19 in a very slight form, like almost nothing; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (Patient got COVID-19 in a very slight form, like almost nothing) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In May 2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Jul-2022, the patient experienced COVID-19 (Patient got COVID-19 in a very slight form, like almost nothing). At the time of the report, COVID-19 (Patient got COVID-19 in a very slight form, like almost nothing) outcome was unknown.            No concomitant medications were reported.  On an unknown date, patient received the 1st booster dose of Moderna COVID-19 Vaccine. In May-2022, patient received the 2nd booster dose of Moderna COVID-19 Vaccine.  It was unknown if any treatment was given to the patient.   Reporter did not allow further contact
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. No information was provided regarding medical history, concurrent conditions, or concomitant medications. In 2015, the patient was inoculated with zoster vaccine live (ZOSTAVAX) as prescriber/administered by a health care provider (strength, dose, dose number, route, anatomical site of vaccination, lot number and expiration date were not provided) for the long-term prevention of shingles and/or zoster-related conditions. On an unknown date (reported as subsequent to the pt's zoster vaccine live (ZOSTAVAX) inoculation), the patient was treated by a healthcare provider for shingles. As a direct and proximate result of zoster vaccine live (ZOSTAVAX) vaccine, pt had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damages in the future. The outcome of herpes zoster was not recovered.  The reporter assessed that the event was related to zoster vaccine live (ZOSTAVAX).
2 hours post influenza vaccine he developed vomiting and after vomiting he was nauseous but better-recovered in 24 hours.
PATIENT PREVIOUSLY RECIEVED 1 DOSE OF PFIZER VACCINE (12/21/202-LOT EJ1685)
Teeth and Jaw ache, upper and lower left side, also tenderness and ache left temporal mandible joint, slight tingling and numbness left lips.  Suficiently severe that saw regular dentist on emergency basis 1 week after injectionX-rays taken, but no obvious infections or absesses.  Dentist suggested was result of grinding of teeth and would eventually subside.  No previous episodes of teeth grinding however.  Now 5 weeks later, still continuous moderate jaw acheoccasionally quite painful, slight end-molar tenderness, slight tenderness in left mandible joint.  Numbness in left lips gone.  Only treatment has been Tylenol, 500 mg, 1 to 3 times/day.
Diarrhea; Threw up; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) and VOMITING (Threw up) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medication history information was provided.  Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for an unknown indication.   On 07-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Aug-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VOMITING (Threw up). On 07-Aug-2021, the patient experienced DIARRHOEA (Diarrhea). At the time of the report, DIARRHOEA (Diarrhea) had not resolved and VOMITING (Threw up) outcome was unknown.            No treatment medications were provided.   This case was linked to MOD-2021-283815 (Parent-Child Link).   See case MOD-2021-283815 for details regarding the child case.
NO ADVERSE REACTIONS. PATIENT WAS TOO YOUNG TO RECEIVE THE VACCINE.
Large area of redness pain and swelling right upper arm involving 1/2 of upper outer arm. No fever. Diagnosed as cellulitis by ER. Treated with KEFLEX.